Index RUT
P/E 16.51
EPS (ttm) 1.41
Insider Own 0.60%
Shs Outstand 49.93M
Perf Week -3.04%
Market Cap 1.16B
Forward P/E 8.78
EPS next Y 2.65
Insider Trans -6.44%
Shs Float 49.30M
Perf Month -1.36%
Income 70.10M
PEG 2.42
EPS next Q 0.64
Inst Own 94.70%
Short Float / Ratio 2.68% / 1.65
Perf Quarter -27.50%
Sales 2.04B
P/S 0.57
EPS this Y -27.60%
Inst Trans -0.54%
Short Interest 1.32M
Perf Half Y -39.39%
Book/sh 17.93
P/B 1.30
EPS next Y 8.03%
ROA 3.80%
Target Price 31.50
Perf Year -37.03%
Cash/sh 5.07
P/C 4.60
EPS next 5Y 6.81%
ROE 7.90%
52W Range 22.63 - 45.55
Perf YTD -44.78%
Dividend 1.56
P/FCF 580.02
EPS past 5Y -8.50%
ROI 9.70%
52W High -48.89%
Beta 1.17
Dividend % 6.70%
Quick Ratio 0.90
Sales past 5Y -0.50%
Gross Margin 71.10%
52W Low 2.87%
ATR 0.62
Employees 3800
Current Ratio 1.80
Sales Q/Q -10.80%
Oper. Margin 3.20%
RSI (14) 38.24
Volatility 2.34% 2.45%
Optionable Yes
Debt/Eq 0.57
EPS Q/Q -20.20%
Profit Margin 3.40%
Rel Volume 0.54
Prev Close 23.85
Shortable Yes
LT Debt/Eq 0.41
Earnings Aug 01 AMC
Payout 105.80%
Avg Volume 803.10K
Price 23.28
Recom 3.00
SMA20 -1.26%
SMA50 -9.56%
SMA200 -34.85%
Volume 434,256
Change -2.39%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-31-23 Downgrade
Jefferies
Buy → Hold
$43 → $39
Feb-12-21 Downgrade
DA Davidson
Buy → Neutral
Oct-02-20 Upgrade
BofA Securities
Underperform → Neutral
$54 → $58
Jul-02-20 Upgrade
Jefferies
Hold → Buy
$42 → $50
Jul-02-20 Upgrade
DA Davidson
Neutral → Buy
Mar-09-20 Downgrade
Deutsche Bank
Buy → Hold
$40 → $28
Dec-05-19 Resumed
Citigroup
Neutral
Nov-06-19 Downgrade
Citigroup
Buy → Neutral
Oct-30-19 Upgrade
Stifel
Sell → Hold
$38.50 → $45
Jul-17-19 Downgrade
Jefferies
Buy → Hold
$40
Jul-17-19 Downgrade
DA Davidson
Buy → Neutral
$38
Jun-19-19 Reiterated
BofA/Merrill
Underperform
$57 → $52
May-01-19 Upgrade
Deutsche Bank
Hold → Buy
May-01-19 Reiterated
BofA/Merrill
Underperform
$52 → $57
Apr-12-19 Reiterated
BofA/Merrill
Underperform
$65 → $52
Mar-25-19 Downgrade
Stifel
Hold → Sell
$63 → $43
Dec-06-18 Reiterated
BofA/Merrill
Underperform
$75 → $65
Oct-10-18 Initiated
DA Davidson
Buy
$92
Aug-03-18 Upgrade
Stifel
Sell → Hold
$57 → $70
Jun-14-18 Initiated
Jefferies
Buy
$98
Show Previous Ratings
Sep-21-23 11:55AM
Sep-06-23 10:26AM
Aug-31-23 11:31AM
Aug-29-23 11:24AM
07:00AM
10:08PM
Loading…
Aug-09-23 10:08PM
Aug-05-23 08:04AM
Aug-02-23 11:39AM
06:49AM
(Thomson Reuters StreetEvents)
Aug-01-23 05:55PM
04:51PM
04:07PM
04:06PM
04:05PM
Jul-27-23 04:05PM
09:05AM
Loading…
09:05AM
08:21AM
Jul-26-23 11:07AM
Jul-18-23 10:32AM
Jul-14-23 09:40AM
Jul-10-23 04:10PM
Jul-08-23 08:32AM
Jun-25-23 11:26AM
Jun-21-23 08:00PM
Jun-09-23 06:23AM
Jun-07-23 12:05PM
Jun-02-23 11:31AM
May-23-23 01:16PM
May-07-23 08:07AM
May-04-23 10:37AM
06:50AM
Loading…
06:50AM
(Thomson Reuters StreetEvents)
May-03-23 06:25PM
05:23PM
04:06PM
04:05PM
May-02-23 11:29AM
11:22AM
May-01-23 10:55AM
Apr-27-23 09:40AM
Apr-26-23 08:00PM
10:02AM
Apr-19-23 04:05PM
09:15AM
Apr-18-23 09:17AM
Mar-30-23 04:20PM
Mar-17-23 03:02PM
11:30AM
Mar-15-23 08:20AM
Mar-07-23 08:34AM
Feb-19-23 07:07AM
Feb-17-23 06:56AM
Feb-16-23 10:06AM
Feb-15-23 06:55PM
05:48PM
04:06PM
04:05PM
Feb-14-23 06:36AM
Feb-13-23 10:27AM
08:08AM
Feb-08-23 10:00AM
09:41AM
Feb-06-23 07:36AM
Jan-11-23 09:30AM
Jan-10-23 12:52PM
Jan-09-23 04:05PM
Dec-31-22 04:30PM
Dec-25-22 07:58AM
Dec-23-22 04:13AM
Dec-12-22 10:15AM
Dec-08-22 01:32PM
Dec-02-22 11:31AM
Nov-29-22 02:25PM
Nov-28-22 06:53PM
05:43PM
Nov-22-22 01:40PM
08:28AM
Nov-18-22 05:30AM
Nov-17-22 01:10PM
04:39AM
Nov-16-22 03:47PM
Nov-09-22 05:45AM
Nov-07-22 03:08PM
Nov-06-22 07:03AM
Nov-03-22 10:08AM
Nov-02-22 06:45PM
04:06PM
04:05PM
Oct-31-22 12:53PM
11:09AM
Oct-26-22 10:01AM
Oct-07-22 10:13AM
Oct-06-22 07:30AM
Oct-04-22 04:05PM
10:15AM
Sep-21-22 04:05PM
Sep-12-22 09:09AM
Sep-09-22 03:57PM
Sep-06-22 10:37AM
Aug-24-22 10:23AM
Aug-21-22 08:11AM
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
LIPMAN ANDREW D Director Aug 25 Sale 23.33 2,000 46,660 56,625 Aug 28 05:04 PM Nathanson Laura Director Aug 21 Sale 24.12 6,068 146,360 10,300 Aug 22 05:33 PM Battle Emma S. Director Aug 07 Sale 26.15 1,272 33,263 7,619 Aug 08 04:33 PM LIPMAN ANDREW D Director Jul 25 Sale 28.99 2,000 57,980 58,625 Jul 25 06:08 PM LIPMAN ANDREW D Director Jun 26 Sale 32.12 2,000 64,240 60,625 Jun 26 06:42 PM LIPMAN ANDREW D Director May 25 Sale 34.28 2,000 68,560 58,393 May 26 04:50 PM WOODBURY EDWINA D Director May 09 Sale 37.87 1,255 47,527 15,469 May 09 06:23 PM LIPMAN ANDREW D Director Apr 25 Sale 40.75 2,000 81,500 60,393 Apr 25 05:25 PM LIPMAN ANDREW D Director Mar 27 Sale 39.29 2,000 78,580 62,393 Mar 27 06:42 PM Hatchett Steven Keith Chief Product Officer Mar 09 Option Exercise 30.45 21,155 644,170 79,523 Mar 09 06:55 PM Hatchett Steven Keith Chief Product Officer Mar 09 Sale 39.78 21,155 841,546 58,368 Mar 09 06:55 PM CHANG JOSEPH Y Chief Scientific Officer Mar 02 Option Exercise 30.45 25,000 761,358 46,234 Mar 03 06:32 PM Lawrence Mark H Chief Financial Officer Mar 02 Option Exercise 30.45 18,041 549,348 83,290 Mar 03 06:34 PM Lawrence Mark H Chief Financial Officer Mar 02 Sale 40.80 26,144 1,066,675 57,146 Mar 03 06:34 PM CHANG JOSEPH Y Chief Scientific Officer Mar 02 Sale 40.77 25,000 1,019,250 21,234 Mar 03 06:32 PM CHANG JOSEPH Y Chief Scientific Officer Mar 01 Option Exercise 30.63 68,485 2,097,696 89,719 Mar 03 06:32 PM CHANG JOSEPH Y Chief Scientific Officer Mar 01 Sale 40.44 68,485 2,769,533 21,234 Mar 03 06:32 PM NAPIERSKI RYAN S President and CEO Feb 28 Option Exercise 30.63 10,000 306,300 178,784 Feb 28 07:46 PM NAPIERSKI RYAN S President and CEO Feb 28 Sale 40.42 10,000 404,154 168,784 Feb 28 07:46 PM NAPIERSKI RYAN S President and CEO Feb 27 Option Exercise 30.63 21,513 658,943 190,297 Feb 28 07:46 PM NAPIERSKI RYAN S President and CEO Feb 27 Sale 41.38 21,513 890,208 168,784 Feb 28 07:46 PM Thomas James D Chief Accounting Officer Feb 23 Sale 41.12 2,829 116,328 17,928 Feb 23 05:58 PM LIPMAN ANDREW D Director Feb 22 Sale 41.42 1,000 41,420 64,393 Feb 23 06:00 PM Battle Emma S. Director Feb 22 Sale 41.70 987 41,158 4,659 Feb 23 06:06 PM LIPMAN ANDREW D Director Jan 23 Sale 42.27 1,000 42,270 65,393 Jan 23 06:58 PM LIPMAN ANDREW D Director Dec 22 Sale 40.75 1,000 40,750 66,393 Dec 22 05:50 PM CHANG JOSEPH Y Chief Scientific Officer Dec 18 Option Exercise 37.58 6,800 255,544 29,757 Dec 20 05:15 PM NAPIERSKI RYAN S President and CEO Nov 25 Option Exercise 33.97 25,000 849,150 147,683 Nov 28 04:48 PM NAPIERSKI RYAN S President and CEO Nov 25 Sale 38.45 25,000 961,250 122,683 Nov 28 04:48 PM LIPMAN ANDREW D Director Nov 22 Sale 38.16 1,000 38,160 67,393 Nov 22 05:40 PM LIPMAN ANDREW D Director Oct 21 Sale 35.92 1,000 35,920 68,393 Oct 24 05:25 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite